Key details
Phase
First-in-human testing / Safety & dosing
Sponsor
Haihe Biopharma Co., Ltd.
Enrollment target
~100 participants
Primary completion
October 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 75 Years
Last updated January 2026